Logo image of NAI.AS

NEW AMSTERDAM INVEST NV (NAI.AS) Stock Fundamental Analysis

AMS:NAI - Euronext Amsterdam - NL0015000CG2 - Common Stock - Currency: EUR

9.35  -0.1 (-1.06%)

Fundamental Rating

1

Overall NAI gets a fundamental rating of 1 out of 10. We evaluated NAI against 0 industry peers in the Unkown industry. NAI has a bad profitability rating. Also its financial health evaluation is rather negative. NAI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year NAI has reported negative net income.
In the past year NAI had a positive cash flow from operations.
NAI.AS Yearly Net Income VS EBIT VS OCF VS FCFNAI.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 -2M -4M

1.2 Ratios

Industry RankSector Rank
ROA -0.52%
ROE -1%
ROIC 3.91%
ROA(3y)-4.2%
ROA(5y)N/A
ROE(3y)-6.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
NAI.AS Yearly ROA, ROE, ROICNAI.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -2 -4 -6 -8 -10

1.3 Margins

Industry RankSector Rank
OM 51.47%
PM (TTM) N/A
GM 78.6%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
NAI.AS Yearly Profit, Operating, Gross MarginsNAI.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 50 -50 -100

More info and screens

1

2. Health

2.1 Basic Checks

NAI has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NAI has more shares outstanding
Compared to 1 year ago, NAI has a worse debt to assets ratio.
NAI.AS Yearly Shares OutstandingNAI.AS Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 1M 2M 3M 4M 5M
NAI.AS Yearly Total Debt VS Total AssetsNAI.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 20M 40M 60M 80M

2.2 Solvency

Based on the Altman-Z score of 0.89, we must say that NAI is in the distress zone and has some risk of bankruptcy.
NAI has a debt to FCF ratio of 18.76. This is a negative value and a sign of low solvency as NAI would need 18.76 years to pay back of all of its debts.
A Debt/Equity ratio of 0.85 indicates that NAI is somewhat dependend on debt financing.
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 18.76
Altman-Z 0.89
ROIC/WACC0.56
WACC7.05%
NAI.AS Yearly LT Debt VS Equity VS FCFNAI.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 10M 20M 30M 40M

2.3 Liquidity

NAI has a Current Ratio of 1.29. This is a normal value and indicates that NAI is financially healthy and should not expect problems in meeting its short term obligations.
A Quick Ratio of 1.29 indicates that NAI should not have too much problems paying its short term obligations.
Industry RankSector Rank
Current Ratio 1.29
Quick Ratio 1.29
NAI.AS Yearly Current Assets VS Current LiabilitesNAI.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 10M 20M 30M 40M

More info and screens

1

3. Growth

3.1 Past

NAI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.14%, which is quite impressive.
The Revenue has grown by 1476.47% in the past year. This is a very strong growth!
EPS 1Y (TTM)86.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%176.6%
Revenue 1Y (TTM)1476.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%733.46%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NAI.AS Yearly Revenue VS EstimatesNAI.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 1M 2M 3M 4M
NAI.AS Yearly EPS VS EstimatesNAI.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

NAI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NAI.AS Price Earnings VS Forward Price EarningsNAI.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF 23.56
EV/EBITDA 17.93
NAI.AS Per share dataNAI.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NAI!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NEW AMSTERDAM INVEST NV

AMS:NAI (3/6/2025, 7:00:00 PM)

9.35

-0.1 (-1.06%)

Chartmill FA Rating
GICS SectorN/A
GICS IndustryGroupN/A
GICS IndustryN/A
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap48.34M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 5.64
P/FCF 23.56
P/OCF 23.55
P/B 1.07
P/tB 1.07
EV/EBITDA 17.93
EPS(TTM)-0.09
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.4
FCFY4.24%
OCF(TTM)0.4
OCFY4.25%
SpS1.66
BVpS8.71
TBVpS8.71
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.52%
ROE -1%
ROCE 5.36%
ROIC 3.91%
ROICexc 4.18%
ROICexgc 4.18%
OM 51.47%
PM (TTM) N/A
GM 78.6%
FCFM 23.93%
ROA(3y)-4.2%
ROA(5y)N/A
ROE(3y)-6.04%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 0.85
Debt/FCF 18.76
Debt/EBITDA 8.71
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 2.19
Cash Conversion 46.46%
Profit Quality N/A
Current Ratio 1.29
Quick Ratio 1.29
Altman-Z 0.89
F-Score5
WACC7.05%
ROIC/WACC0.56
Cap/Depr(3y)232.54%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%176.6%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)1476.47%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%733.46%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y368.98%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y267.24%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y270.09%
OCF growth 3YN/A
OCF growth 5YN/A